Prosight Management, LP - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 76 filers reported holding CUE BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Prosight Management, LP ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q1 2023$4,112,122
-21.6%
1,151,855
-37.4%
1.95%
-31.9%
Q4 2022$5,245,454
+52.2%
1,840,510
+19.1%
2.86%
+54.9%
Q3 2022$3,447,000
-16.4%
1,545,573
-6.6%
1.85%
-43.1%
Q2 2022$4,122,000
-44.1%
1,655,477
+9.6%
3.25%
-31.8%
Q1 2022$7,370,000
-21.4%
1,510,282
+82.2%
4.76%
-15.2%
Q4 2021$9,376,000
-1.8%
829,042
+26.5%
5.61%
+6.9%
Q3 2021$9,546,000
+30.0%
655,185
+3.9%
5.25%
+14.4%
Q2 2021$7,344,000
+8.1%
630,364
+13.2%
4.59%
-17.4%
Q1 2021$6,793,000
-40.1%
556,777
-38.6%
5.56%
+6.1%
Q4 2020$11,341,000
+6.1%
906,569
+27.7%
5.24%
+3.1%
Q3 2020$10,685,000
+40.5%
709,936
+128.8%
5.08%
+55.7%
Q2 2020$7,605,000
-2.9%
310,294
-43.8%
3.26%
-10.9%
Q1 2020$7,834,000
+258.5%
552,060
+301.1%
3.66%
+281.9%
Q4 2019$2,185,000137,6280.96%
Other shareholders
CUE BIOPHARMA INC shareholders Q1 2020
NameSharesValueWeighting ↓
Corriente Advisors, LLC 1,437,445$21,634,00010.97%
Prosight Management, LP 709,936$10,685,0005.08%
Voss Capital, LP 226,573$3,410,0001.94%
Robertson Stephens Wealth Management, LLC 484,000$7,284,0001.79%
Slate Path Capital LP 1,483,619$22,328,0001.27%
Nantahala Capital Management 2,342,216$35,250,0001.08%
SANDERS MORRIS HARRIS LLC 142,430$2,312,0000.63%
Rock Creek Group, LP 80,000$1,204,0000.62%
PRECEPT MANAGEMENT LLC 150,000$2,258,0000.55%
PA Capital LLC 46,850$705,0000.50%
View complete list of CUE BIOPHARMA INC shareholders